ABBOTT LABORATORIES — Director's Dealing 2015

Jun 5, 2015

SEC FORM 4 Page 1 of 2

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

OMB APPROVAL OMB Number: 3235-0267 Estimated average burden hours per response: 0.5

☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

| 1. Name and Address of Reporting Person Pavee Jean-Yves | | | 2. Issuer Name and Ticker or Trading Symbol ABBOTT LABORATORIES [ ABT ] | | | | | | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Senior Vice President | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | (Last) (First) (Middle) 100 ABBOTT PARK ROAD | | | 3. Date of Earliest Transaction (Month/Day/Year) 06/03/2015 | | | | | | | | | | (Street) ABBOTT PARK IL 60064 | | | 4. If Amendment, Date of Original Filed (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | | | | | | | | | (City) (State) (Zip) | | | | | | | | | | | | | Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | | | | | | | | | | | | | 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 6) | | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | | | | | | | Code | V | Amount | (A) or (D) | | | | | | | Common shares without par value | | | 06/03/2015 | | M | | 5,200 | A | $25,2461 | 30,806 | D | | Common shares without par value | | | 06/03/2015 | | M | | 5,300 | A | $26,6973 | 36,106 | D | | Common shares without par value | | | 06/03/2015 | | S | | 10,500 | D | $49 | 25,606 | D | | Common shares without par value | | | | | | | | | | 2,711 (1) | I | | Common shares without par value | | | | | | | | | | 2,966 (2) | I | | Common shares without par value | | | | | | | | | | 2,967 (2) | I | | Common shares without par value | | | | | | | | | | 2,966 (3) | I | | Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | | | | | | | | | | | | | 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 6) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | | 6. Date Exercisable and Expiration Date (Month/Day/Year) | | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | | | | | | Code | V | (A) | (D) | Date Exercisable | Expiration Date | | | | Option (right to buy) (4) | $25,2461 | 06/03/2015 | | M | | 5,200 | 02/16/2010 | 02/15/2017 | Common shares | 5,200 | $0 | | Option (right to buy) (4) | $26,6973 | 06/03/2015 | | M | | 5,300 | 02/15/2011 | 02/14/2018 | Common shares | 5,300 | $0 |

Explanation of Responses:

1. Balance in the Abbott Laboratories Stock Retirement Trust as of June 4, 2015.
2. The reporting person disclaims beneficial ownership of all securities held by his daughter.
3. The reporting person disclaims beneficial ownership of all securities held by his son.
4. Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).

John A. Berry, by power of attorney for Jean-Yves Pavee 06/05/2015

** Signature of Reporting Person Date

http://www.sec.gov/Archives/edgar/data/1800/000117911015009279/xslF345X03/edgar.xml 6/5/2015

---

SEC FORM 4 Page 2 of 2

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

• If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

http://www.sec.gov/Archives/edgar/data/1800/000117911015009279/xslF345X03/edgar.xml 6/5/2015